Advertisement
Review Article| Volume 33, ISSUE 4, P861-866, December 2013

Download started.

Ok

Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix

Published:October 17, 2013DOI:https://doi.org/10.1016/j.cll.2013.08.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vogelstein B.
        • Fearon E.R.
        • Stanley S.R.
        • et al.
        Genetic alterations during colorectal tumor development.
        N Engl J Med. 1988; 319: 525-532
        • Noffsinger A.
        Epithelial neoplasms of the small intestine.
        in: Odze R.D. Goldblum J.R. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Saunders Elsevier, Philadelphia, PA2009: 581-596
        • Thomas R.M.
        • Sobin L.H.
        Gastrointestinal cancer: incidence and prognosis by histologic type: SEER population-based data, 1973–1987.
        Cancer. 1995; 75: 154-170
        • Misdraji J.
        • Burgart L.J.
        • Lauwers G.Y.
        Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas.
        Mod Pathol. 2004; 17: 1447-1454
        • Maru D.
        • Wu T.T.
        • Canada A.
        • et al.
        Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
        Oncogene. 2004; 23: 859-864
        • Straker R.J.
        • Gunasekaran S.
        • Brady P.G.
        Adenocarcinoma of the jejunum in association with celiac sprue.
        J Clin Gastroenterol. 1989; 11: 320-323
        • Rampertab S.D.
        • Forde K.A.
        • Green P.H.
        Small bowel neoplasia in coeliac disease. Case report.
        Gut. 2003; 52: 1211-1214
        • Popovici V.
        • Budinska E.
        • Tejpar S.
        • et al.
        Identification of a poor-prognosis BRAF-mutant–like population of patients with colon cancer.
        J Clin Oncol. 2012; 30: 1288-1295
        • Di Nicolantonio F.
        • Martini M.
        • Molinari F.
        • et al.
        Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
        J Clin Oncol. 2008; 26: 5705-5712
        • Mitomi H.
        • Nakamura T.
        • Ihara A.
        • et al.
        Frequent Ki-ras mutations and transforming growth factor-α expression in adenocarcinomas of the small intestine: report of 7 cases.
        Dig Dis Sci. 2003; 48: 203-209
        • Lynch H.T.
        • Smyrk T.C.
        • Lynch P.M.
        • et al.
        Adenocarcinoma of the small bowel in Lynch syndrome II.
        Cancer. 1989; 64: 2178-2183
        • Baczako K.
        • Buchler M.
        • Beger H.G.
        • et al.
        Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma.
        Hum Pathol. 1985; 16: 305-310
        • Kimura W.
        • Futakawa N.
        • Yamagata S.
        • et al.
        Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.
        Jpn J Cancer Res. 1994; 85: 161-165
        • Talbot I.C.
        • Neoptolemos J.P.
        • Shaw D.E.
        • et al.
        The histopathology and staging of carcinoma of the ampulla of Vater.
        Histopathology. 1988; 12: 155-165
        • Arai M.
        • Shimizu S.
        • Imai Y.
        • et al.
        Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine.
        Int J Cancer. 1997; 70: 390-395
        • Arber N.
        • Shapira I.
        • Ratan J.
        • et al.
        Activation of c-kras mutations in human gastrointestinal tumors.
        Gastroenterology. 2000; 118: 1045-1050
        • Sutter T.
        • Arber N.
        • Moss S.F.
        • et al.
        Frequent K-ras mutations in small bowel adenocarcinomas.
        Dig Dis Sci. 1996; 41: 115-118
        • Younes N.
        • Fulton N.
        • Tanaka R.
        • et al.
        The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
        Cancer. 1997; 79: 1804-1808
        • Wheeler J.M.
        • Warren B.F.
        • Mortensen N.J.
        • et al.
        An insight into the genetic pathway of adenocarcinoma of the small intestine.
        Gut. 2002; 50: 218-223
        • Benatti P.
        • Roncucci L.
        • Percesepe A.
        • et al.
        Small bowel carcinoma in hereditary nonpolyposis colorectal cancer.
        Am J Gastroenterol. 1998; 93: 2219-2222
        • Planck M.
        • Ericson K.
        • Piotrowska Z.
        • et al.
        Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
        Cancer. 2003; 97: 1551-1557
        • Vasen H.F.
        • Wijnen J.T.
        • Menko F.H.
        • et al.
        Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.
        Gastroenterology. 1996; 110: 1020-1027
        • Rashid A.
        • Hamilton S.R.
        Genetic alterations in sporadic and Crohn’s associated adenocarcinomas of the small intestine.
        Gastroenterology. 1997; 113: 127-135
        • Overman M.J.
        • Pozadzides J.
        • Kopetz1 S.
        • et al.
        Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.
        Br J Cancer. 2010; 102: 144-150
        • Blaker H.
        • von Herbay A.
        • Penzel R.
        • et al.
        Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
        Oncogene. 2002; 21: 158
        • Brueckl W.M.
        • Heinze E.
        • Milsmann C.
        • et al.
        Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine.
        Cancer Lett. 2004; 203: 181-190
        • Boland C.R.
        • Thibodeau S.N.
        • Hamilton S.R.
        • et al.
        A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
        Cancer Res. 1998; 58: 5248-5257
        • Amado R.G.
        • Wolf M.
        • Peeters M.
        • et al.
        Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
        J Clin Oncol. 2008; 26: 1626-1634
      1. NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines). Colon cancer. Version 3. 2013. Available at: nccn.org. Accessed September 7, 2013.

        • Sargent D.J.
        • Marsoni S.
        • Monges G.
        Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
        J Clin Oncol. 2010; 28: 3219-3226
        • Lievre A.
        • Bachet J.B.
        • Boige V.
        • et al.
        KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
        J Clin Oncol. 2008; 26: 374-379